DNA损伤修复通路功能性胚系变异与接受替莫唑胺治疗的成人胶质瘤生存改变相关
研究基于UCSF成人胶质瘤研究与Mayo Clinic共1504例胶质瘤患者,评估34个DNA修复基因的致病性胚系SNP及遗传预测转录水平与替莫唑胺(TMZ)相关生存的关联;接受TMZ者中5个SNP与总生存相关,未接受TMZ者无此关联。
要点
- 接受TMZ的胶质瘤患者中,MGMT基因rs2308321-G与所有亚型总生存降低相关(HR=1.21,P=0.019)。
- rs73191162-T、rs13076508-C、rs7840433-A、rs3130618-A仅在特定亚型中与TMZ治疗生存相关。
- TMZ治疗的IDH突变且1p/19q非共缺失胶质瘤中,PNKP表达升高与总生存显著不良相关(P=0.015,中位生存差异超过70个月)。
核心结论
- DNA修复基因的功能性胚系变异与成人胶质瘤患者接受TMZ治疗后的总生存相关,这些变异应在前瞻性分析和功能研究中评估。
研究设计与样本
- 研究纳入来自加州大学旧金山分校成人胶质瘤研究(UCSF AGS)和Mayo Clinic的1504例胶质瘤患者,诊断时间跨越TMZ前时代与TMZ后时代,覆盖主要已知胶质瘤预后分子亚型。
- 评估34个DNA修复基因中致病性胚系SNP及遗传预测转录水平与TMZ相关生存的关联。
主要发现
- 接受TMZ者中5个SNP与总生存相关,未接受TMZ者中无此关联。
- MGMT基因rs2308321-G与所有胶质瘤亚型总生存降低相关(HR=1.21,P=0.019)。
- rs73191162-T(near UNG)、rs13076508-C(near PARP3)、rs7840433-A(near NEIL2)、rs3130618-A(near MSH5)仅在特定亚型中与生存及TMZ治疗相关。
- TMZ治疗的IDH突变且1p/19q非共缺失胶质瘤中,遗传预测PNKP表达升高较正常脑表达与总生存显著不良相关(P=0.015),总生存时间中位差异超过70个月。
- NEIL2和TDG表达仅在特定亚型中与TMZ相关生存改变相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Temozolomide (TMZ) treatment has demonstrated a variable impact on glioma prognosis. This study examines associations of survival with DNA repair gene germline polymorphisms among glioma patients who did and did not have TMZ treatment. Identifying genetic markers which sensitize tumor cells to TMZ could personalize therapy and improve outcomes. METHODS: We evaluated TMZ-related survival associations of pathogenic germline SNPs and genetically predicted transcript levels within 34 DNA repair genes among 1504 glioma patients from the University of California San Francisco Adult Glioma Study (UCSF AGS) and Mayo Clinic, whose diagnoses spanned pre- and post-TMZ eras within the major known glioma prognostic molecular subtypes. RESULTS: Among those who received TMZ, 5 SNPs were associated with overall survival, but not in those who did not receive TMZ. Only rs2308321-G, in MGMT, was associated with decreased survival (hazard ratio = 1.21, P = .019) for all glioma subtypes. Rs73191162-T (near UNG), rs13076508-C (near PARP3), rs7840433-A (near NEIL2), and rs3130618-A (near MSH5) were only associated with survival and TMZ treatment for certain subtypes, suggesting subtype-specific germline chemosensitization. Genetically predicted elevated expression of PNKP, compared to normal brain expression, was associated with markedly poor survival in TMZ-treated patients with isocitrate dehydrogenase (IDH)-mutant and 1p/19q non-codeleted gliomas (P = .015), with a median difference of over 70 months in overall survival times. Similarly, NEIL2 and TDG expressions were associated with altered TMZ-related survival only among certain subtypes. CONCLUSIONS: Functional germline alterations within DNA repair genes were associated with TMZ sensitivity, measured by overall survival among adults with glioma. These variants should be evaluated in prospective analyses and functional studies.
引用
- Guerra G, Wendt G, McCoy L, et al. Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. Neuro Oncol. 2025. PMID: 39745907. doi:10.1093/neuonc/noae275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。